A deadly, drug-resistant hospital fungus may finally have a weakness—and scientists think they’ve found it.

Scientists have discovered a genetic process which could unlock new ways to treat a mysterious and deadly fungal infection ...

Scientists have discovered a genetic process which could unlock new ways to treat mysterious and deadly fungal infection which has shut down multiple ...

XV, a 15–amino acid human-derived peptide that safely kills fungi causing keratitis, promotes corneal healing, resists drug ...

Michigan hospitals face a rising drug-resistant fungus, Candida auris, highlighting broader concerns over antimicrobial resistance.

Doctors are reporting a rise in skin rashes and fungal infections during winter, linked to repeatedly wearing unwashed ...

Now, the Lundquist Institute (TLI) and Vitalex Biosciences announce that they will move forward in the development of the second-generation fungal vaccine candidate known as VXV‑01—up to and including ...

The microbiome not only consists of bacteria, but also of fungi. Most of them support human and animal health. However, some ...

The contract, awarded by NIH/NIAID, provides up to US $40 million of non-dilutive funding to Vitalex and its collaborator Appili and for the comprehensive development of VXV-01.

The yeast Candida albicans colonizes mucosal surfaces and is usually harmless. However, under certain conditions it can cause dangerous infections.

The Lundquist Institute (TLI) and its start-up company Vitalex Biosciences (Vitalex) are pleased to announce that the second-generation fungal vaccine candidate known as VXV--01, which was developed ...